H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Applied DNA Sciences (APDN) today and set a price target of $22.00. The company’s shares closed last Friday at $7.64.
According to TipRanks.com, Chen is a 4-star analyst with an average return of 5.0% and a 37.8% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $21.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $19.69 and a one-year low of $2.52. Currently, Applied DNA Sciences has an average volume of 1.27M.
Based on the recent corporate insider activity of 14 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
